(a) TPCK is specific for chymotrypsin because the phenyl ring of the Phe residue interacts effectively with the binding pocket of the chymotrypsin active site. This positions the chloromethyl group to react with His57. This reaction and binding occurs in the same way as peptide binding and hydrolysis. Thus, the correct option is the phenyl group of TPCK is structurally similar to chymotrypsin substrates.
(b) Replacement of the Phe residue of TPCK with arginine or lysine produces reagents that are specific for trypsin.So, looking at the given structures, the best fitted structure is B.
N-Tosylamido-L-phenylethyl, also called tosyl phenylalanyl chloromethyl ketone, (TPCK) irreversibly inhibits chymotrypsin, and is used as to...
1. Tosyl-L-phenylalanine chloromethyl ketone (TPCK) is an inhibitor of chymotrypsin that binds in the active site and is covalently linked to His57. CHCH-C-CH- a. b. c. What type of enzymatic inhibitor is TPCK? Why is this inhibitor specific for chymotrypsin? Briefly describe two aspects of the chymotrypsin mechanism that are affected by TPCK NH CH
Question 89 Gluconeogenesis is the A) Result of amylase activity B) Formation of glycogen C) Formation of starches D) Formation of glucose from simple two and three-carbon precursors Question 90 The only known regulatory mechanism for pyruvate carbora A) Activation by acetyl Co4 B) Activation by phosphorylation C) Activation by CAMP D) Activation by NADH 20 5 Question 87 Isozymes are enzymes A) From one species that catalyze the same reaction B) From different species that catalyze the same reaction...
1. According to the paper, what does lactate dehydrogenase
(LDH) do and what does it allow to happen within the myofiber? (5
points)
2. According to the paper, what is the major disadvantage of
relying on glycolysis during high-intensity exercise? (5
points)
3. Using Figure 1 in the paper, briefly describe the different
sources of ATP production at 50% versus 90% AND explain whether you
believe this depiction of ATP production applies to a Type IIX
myofiber in a human....